Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases

George Thomas, Kinga Szigeti, Michael Murphy, Giulio Draetta, Michele Pagano, Massimo Loda

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

The cyclin-dependent kinase inhibitor p27 is a negative regulator of the cell cycle and a potential tumor suppressor gene. Because we had previously demonstrated that loss of p27 protein is associated with aggressive behavior in colorectal adenocarcinomas, we used immunohistochemistry and in situ hybridization to evaluate the potential role of alterations in p27 expression in primary and metastatic colorectal adenocarcinomas. Parallel immunostaining was performed for Ki-67 and p53. We evaluated 13 cases of metachronous and 23 cases of synchronous primary and metastatic colorectal tumor pairs. In the synchronous subgroup (Stage IV tumors), 57% of the primary tumor and metastases pairs did not express p27 protein and the remainder were low expressors. In the metachronous subgroup, 54% of the primary tumors were low expressors and the remainder high expressors of p27 protein. There was a significant reduction in the expression of p27 in the metachronous metastases (mean positive cells: 14.5%) when compared to the corresponding primary tumors (mean positive cells: 41.8%), P = 0.0023. All the primary and metastatic tumors in the metachronous subgroup showed high levels of p27 mRNA expression. There was no association between loss of p27 and either Ki-67 count or p53 expression. Because p27 is known to be up-regulated when epithelial cells are grown in suspension, the down-regulation of p27 in circulating tumor cells may confer the ability to grow in an environment of altered extracellular matrix or intercellular adhesion properties, two situations which may facilitate metastases.

Original languageEnglish (US)
Pages (from-to)681-687
Number of pages7
JournalAmerican Journal of Pathology
Volume153
Issue number3
StatePublished - Sep 1998
Externally publishedYes

Fingerprint

Adenocarcinoma
Down-Regulation
Neoplasm Metastasis
Neoplasms
Cyclin-Dependent Kinase Inhibitor p27
Circulating Neoplastic Cells
Proteins
Tumor Suppressor Genes
In Situ Hybridization
Extracellular Matrix
Colorectal Neoplasms
Suspensions
Cell Cycle
Epithelial Cells
Immunohistochemistry
Messenger RNA

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Thomas, G., Szigeti, K., Murphy, M., Draetta, G., Pagano, M., & Loda, M. (1998). Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. American Journal of Pathology, 153(3), 681-687.

Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. / Thomas, George; Szigeti, Kinga; Murphy, Michael; Draetta, Giulio; Pagano, Michele; Loda, Massimo.

In: American Journal of Pathology, Vol. 153, No. 3, 09.1998, p. 681-687.

Research output: Contribution to journalArticle

Thomas, G, Szigeti, K, Murphy, M, Draetta, G, Pagano, M & Loda, M 1998, 'Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases', American Journal of Pathology, vol. 153, no. 3, pp. 681-687.
Thomas, George ; Szigeti, Kinga ; Murphy, Michael ; Draetta, Giulio ; Pagano, Michele ; Loda, Massimo. / Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. In: American Journal of Pathology. 1998 ; Vol. 153, No. 3. pp. 681-687.
@article{7984546925ab49d09a64314298e2657c,
title = "Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases",
abstract = "The cyclin-dependent kinase inhibitor p27 is a negative regulator of the cell cycle and a potential tumor suppressor gene. Because we had previously demonstrated that loss of p27 protein is associated with aggressive behavior in colorectal adenocarcinomas, we used immunohistochemistry and in situ hybridization to evaluate the potential role of alterations in p27 expression in primary and metastatic colorectal adenocarcinomas. Parallel immunostaining was performed for Ki-67 and p53. We evaluated 13 cases of metachronous and 23 cases of synchronous primary and metastatic colorectal tumor pairs. In the synchronous subgroup (Stage IV tumors), 57{\%} of the primary tumor and metastases pairs did not express p27 protein and the remainder were low expressors. In the metachronous subgroup, 54{\%} of the primary tumors were low expressors and the remainder high expressors of p27 protein. There was a significant reduction in the expression of p27 in the metachronous metastases (mean positive cells: 14.5{\%}) when compared to the corresponding primary tumors (mean positive cells: 41.8{\%}), P = 0.0023. All the primary and metastatic tumors in the metachronous subgroup showed high levels of p27 mRNA expression. There was no association between loss of p27 and either Ki-67 count or p53 expression. Because p27 is known to be up-regulated when epithelial cells are grown in suspension, the down-regulation of p27 in circulating tumor cells may confer the ability to grow in an environment of altered extracellular matrix or intercellular adhesion properties, two situations which may facilitate metastases.",
author = "George Thomas and Kinga Szigeti and Michael Murphy and Giulio Draetta and Michele Pagano and Massimo Loda",
year = "1998",
month = "9",
language = "English (US)",
volume = "153",
pages = "681--687",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases

AU - Thomas, George

AU - Szigeti, Kinga

AU - Murphy, Michael

AU - Draetta, Giulio

AU - Pagano, Michele

AU - Loda, Massimo

PY - 1998/9

Y1 - 1998/9

N2 - The cyclin-dependent kinase inhibitor p27 is a negative regulator of the cell cycle and a potential tumor suppressor gene. Because we had previously demonstrated that loss of p27 protein is associated with aggressive behavior in colorectal adenocarcinomas, we used immunohistochemistry and in situ hybridization to evaluate the potential role of alterations in p27 expression in primary and metastatic colorectal adenocarcinomas. Parallel immunostaining was performed for Ki-67 and p53. We evaluated 13 cases of metachronous and 23 cases of synchronous primary and metastatic colorectal tumor pairs. In the synchronous subgroup (Stage IV tumors), 57% of the primary tumor and metastases pairs did not express p27 protein and the remainder were low expressors. In the metachronous subgroup, 54% of the primary tumors were low expressors and the remainder high expressors of p27 protein. There was a significant reduction in the expression of p27 in the metachronous metastases (mean positive cells: 14.5%) when compared to the corresponding primary tumors (mean positive cells: 41.8%), P = 0.0023. All the primary and metastatic tumors in the metachronous subgroup showed high levels of p27 mRNA expression. There was no association between loss of p27 and either Ki-67 count or p53 expression. Because p27 is known to be up-regulated when epithelial cells are grown in suspension, the down-regulation of p27 in circulating tumor cells may confer the ability to grow in an environment of altered extracellular matrix or intercellular adhesion properties, two situations which may facilitate metastases.

AB - The cyclin-dependent kinase inhibitor p27 is a negative regulator of the cell cycle and a potential tumor suppressor gene. Because we had previously demonstrated that loss of p27 protein is associated with aggressive behavior in colorectal adenocarcinomas, we used immunohistochemistry and in situ hybridization to evaluate the potential role of alterations in p27 expression in primary and metastatic colorectal adenocarcinomas. Parallel immunostaining was performed for Ki-67 and p53. We evaluated 13 cases of metachronous and 23 cases of synchronous primary and metastatic colorectal tumor pairs. In the synchronous subgroup (Stage IV tumors), 57% of the primary tumor and metastases pairs did not express p27 protein and the remainder were low expressors. In the metachronous subgroup, 54% of the primary tumors were low expressors and the remainder high expressors of p27 protein. There was a significant reduction in the expression of p27 in the metachronous metastases (mean positive cells: 14.5%) when compared to the corresponding primary tumors (mean positive cells: 41.8%), P = 0.0023. All the primary and metastatic tumors in the metachronous subgroup showed high levels of p27 mRNA expression. There was no association between loss of p27 and either Ki-67 count or p53 expression. Because p27 is known to be up-regulated when epithelial cells are grown in suspension, the down-regulation of p27 in circulating tumor cells may confer the ability to grow in an environment of altered extracellular matrix or intercellular adhesion properties, two situations which may facilitate metastases.

UR - http://www.scopus.com/inward/record.url?scp=0031689717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031689717&partnerID=8YFLogxK

M3 - Article

C2 - 9736017

AN - SCOPUS:0031689717

VL - 153

SP - 681

EP - 687

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -